Causes and treatment of vitreous hemorrhage

Comprehensive Ophthalmology Update

Volumn 7, Issue 3, 2006, Pages 97-111

  Goff, Mitchell J ^a   McDonald, H Richard ^a,b,c,d   Johnson, Robert N ^a,b,d   Ai, Everett ^a,b,d   Jumper, J Michael ^a,b,d   Fu, Arthur D ^a,b,d  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b ST MARY S MEDICAL CENTER   (United States)

^c Novartis Ophthalmics ^*  (United States)

^d ALCON RESEARCH LTD   (United States)

Author keywords

Hemorrhage; Vitrase ; Vitrectomy; Vitreous

Indexed keywords

ACETYLSALICYLIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYALURONIDASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANEURYSM; ANTICOAGULATION; CLINICAL FEATURE; CLINICAL TRIAL; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG MECHANISM; FIBRINOLYSIS; GLAUCOMA; HEMOGLOBINOPATHY; HUMAN; INJURY; INTRAOCULAR TUMOR; IRITIS; LASER COAGULATION; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSIOLOGY; RETINA MACULA DEGENERATION; RETINA TEAR; REVIEW; TOXICITY; TREATMENT OUTCOME; TUMOR; VITRECTOMY; VITREORETINOPATHY; VITREOUS BODY DETACHMENT; VITREOUS HEMORRHAGE;

ANIMALS; CRYOTHERAPY; FIBRINOLYTIC AGENTS; HUMANS; INJECTIONS; PLASMIN; PROGNOSIS; VITRECTOMY; VITREOUS BODY; VITREOUS HEMORRHAGE;

EID: 33746843557     PISSN: 15277313     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (120)

1. Lindgren G, Sjödell L, Lindblom B: A prospective study of dense spontaneous vitreous hemorrhage. Am J Ophthalmol 119: 458-65, 1995
2. Morris DA, Henkind P: Relationship of intracranial, optic-nerve sheath and retinal hemorrhage. Am J Ophthalmol 64: 853-9, 1967
3. Gass J: Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment. St. Louis, CV Mosby, 1987, p 564
4. Greenwald MJ, Weiss A, Oesterle CS, et al: Traumatic retinoschisis in battered babies. Ophthalmology 93: 618-25, 1986
5. Regnault FR: Vitreous hemorrhage: an experimental study. I. A macroscopic and isotopic study of the evolution of whole blood and hemoglobin. Arch Ophthalmol 83: 458-65, 1970
6. Constable IJ, Oguri M, Chesney CM, et al: Platelet-induced vitreous membrane formation. Invest Ophthalmol 12: 680-5, 1973
7. Swann DA, Chesney CM, Constable IJ, et al: The role of vitreous collagen in platelet aggregation in vitro and in vivo. J Lab Clin Med 84: 264-74, 1974
8. Forrester JV, Prentice CR, Williamson J, et al: Fibrinolytic activity of the vitreous body. Invest Ophthalmol 13: 875-9, 1974
9. Forrester J V, Lee WR, Williamson J: The pathology of vitreous hemorrhage. I. Gross and histological appearances. Arch Ophthalmol 96: 703-10, 1978
10. Forrester JV, Grierson I, Lee WR: The pathology of vitreous hemorrhage. II. Ultrastructure. Arch Ophthalmol 97: 2368-74, 1979
11. Ueno A: [Experimental vitreous hemorrhage. II. Absorption of vitreous hemorrhage (author's transl)]. Nippon Ganka Gakkai Zasshi 84: 411-20, 1980
12. Ueno A: [Experimental vitreous hemorrhage. 1. Gross and histopathological observations in the vitreous (author's transl)]. Nippon Ganka Gakkai Zasshi 84: 257-69, 1980
13. Squire C, Mc Ewen WK: The effect of iron compounds on rabbit vitreous. Am J Ophthalmol 46: 356-8, 1958
14. Hofmann H, Schmut O: The inability of superoxide dismutase to inhibit the depolymerization of hyaluronic acid by ferrous ions and ascorbate. Albrecht Von Graefes Arch Klin Exp Ophthalmol 214: 181-5, 1980
15. Chew EY, Klein ML, Murphy RP, et al: Effects of aspirin on vitreous/preretinal hemorrhage in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report no. 20. Arch Ophthalmol 113: 52-5, 1995
16. Banerjee S, Denniston AK, Gibson JM, et al: Does cardiovascular therapy affect the onset and recurrence of preretinal and vitreous haemorrhage in diabetic eye disease? Eye 18: 821-5, 2004
17. Bloome MA, Ruiz RS: Massive spontaneous subretinal hemorrhage. Am J Ophthalmol 86: 630-7, 1978
18. el Baba F, Jarrett WH, Harbin TS, et al: Massive hemorrhage complicating age-related macular degeneration. Clinicopathologic correlation and role of anticoagulants. Ophthalmology 93: 1581-92, 1986
19. Feman SS, Bartlett RE, Roth AM, et al: Intraocular hemorrhage and blindness associated with systemic anticoagulation. JAMA 220: 1354-5, 1972
20. Lewis H, Sloan SH, Foos RY: Massive intraocular hemorrhage associated with anticoagulation and age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 226: 59-64, 1988
21. Spraul CW, Grossniklaus HE: Vitreous Hemorrhage. Surv Ophthalmol 42: 3-39, 1997
22. Thompson JT, Stoessel KM: An analysis of the effect of intravitreal blood on visual acuity. Am J Ophthalmol 104: 353-7, 1987
23. Lu ZL: [Experimental studies on the role of retinal lipid peroxidation induced by intraocular iron foreign body]. Zhonghua Yi Xue Za Zhi 69: 690-1, 1989
24. Doly M, Bonhomme B, Vennat JC: Experimental study of the retinal toxicity of hemoglobinic iron. Ophthalmic Res 18: 21-7, 1986
25. Ehrenberg M, Thresher RJ, Machemer R: Vitreous hemorrhage nontoxic to retina as a stimulator of glial and fibrous proliferation. Am J Ophthalmol 97: 611-26, 1984
26. Kono T: [Reaction of retinal glial cells to form preretinal membrane induced by vitreous hemorrhage]. Nippon Ganka Gakkai Zasshi 91: 911-22, 1987
27. Lean JS, Gregor Z: The acute vitreous haemorrhage. Br J Ophthalmol 64: 469-71, 1980
28. Tseng W, Cortez RT, Ramirez G, et al: Prevalence and risk factors for proliferative vitreoretinopathy in eyes with rhegmatogenous retinal detachment but no previous vitreoretinal surgery. Am J Ophthalmol 137: 1105-15, 2004
29. Chiquet C, Gain P, Zech JC, et al: [Risk factors for secondary retinal detachment after extraction of intraocular foreign bodies.]. Can J Ophthalmol 37: 168-76, 2002
30. Campbell DG, Simmons RJ, Grant WM: Ghost cells as a cause of glaucoma. Am J Ophthalmol 81: 441-50, 1976
31. Montenegro MH, Simmons RJ: Ghost cell glaucoma. Int Ophthalmol Clin 35: 111-5, 1995
32. Morse PH, Aminlari A, Scheie HG: Spontaneous vitreous hemorrhage. Arch Ophthalmol 92: 297-8, 1974
33. Winslow RL, Taylor BC: Spontaneous vitreous hemorrhage: etiology and management. South Med J 73: 1450-2, 1980
34. Butner RW, McPherson AR: Spontaneous vitreous hemorrhage. Ann Ophthalmol 14: 268-70, 1982
35. Dana MR, Werner MS, Viana MA, et al: Spontaneous and traumatic vitreous hemorrhage. Ophthalmology 100: 1377-83, 1993
36. Cordido M, Fernández-Vigo J, Fandiño J, et al: Natural evolution of massive vitreous hemorrhage in diabetic retinopathy. Retina 8: 96-101, 1988
37. Ziemianski MC, McMeel JW, Franks EP: Natural history of vitreous hemorrhage in diabetic retinopathy. Ophthalmology 87: 306-12, 1980
38. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Two-year results of a randomized trial. Diabetic Retinopathy Vitrectomy Study report 2. The Diabetic Retinopathy Vitrectomy Study Research Group. Arch Ophthalmol 103: 1644-52, 1985
39. Hayreh SS, Rojas P, Podhajsky P, et al: Ocular neovascularization with retinal vascular occlusion-III. Incidence of ocular neovascularization with retinal vein occlusion. Ophthalmology 90: 488-506, 1983
40. Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Branch Vein Occlusion Study Group. Arch Ophthalmol 104: 34-41, 1986
41. Trempe CL, Takahashi M, Topilow HW: Vitreous changes in retinal branch vein occlusion. Ophthalmology 88: 681-7, 1981
42. Panton RW, Goldberg MF, Farber MD: Retinal arterial macroaneurysms: risk factors and natural history. Br J Ophthalmol 74: 595-600, 1990
43. Rabb MF, Gagliano DA, Teske MP: Retinal arterial macroaneurysms. Surv Ophthalmol 33: 73-96, 1988
44. Tezel T, Günalp I, Tezel G: Morphometrical analysis of retinal arterial macroaneurysms. Doc Ophthalmol 88: 113-25, 1994
45. Nadel AJ, Gupta KK: Macroaneurysms of the retinal arteries. Arch Ophthalmol 94: 1092-6, 1976
46. Tonotsuka T, Imai M, Saito K, et al: Visual prognosis for symptomatic retinal arterial macroaneurysm. Jpn J Ophthalmol 47: 498-502, 2003
47. Welch RB, Goldberg MF: Sickle-cell hemoglobin and its relation to fundus abnormality. Arch Ophthalmol 75: 353-62, 1966
48. Downes SM, Hambleton IR, Chuang EL, et al: Incidence and natural history of proliferative sickle cell retinopathy: observations from a cohort study. Ophthalmology 112: 1869-75, 2005
49. Clarkson JG: The ocular manifestations of sickle-cell disease: a prevalence and natural history study Trans Am Ophthalmol Soc 90: 481-504, 1992
50. Byer NE: Natural history of posterior vitreous detachment with early management as the premier line of defense against retinal detachment. Ophthalmology 101: 1503-13; discussion 1513-4, 1994
51. Novak MA, Welch RB: Complications of acute symptomatic posterior vitreous detachment. Am J Ophthalmol 97: 308-14, 1984
52. Sarrafizadeh R, Hassan TS, Ruby AJ, et al: Incidence of retinal detachment and visual outcome in eyes presenting with posterior vitreous separation and dense fundus-obscuring vitreous hemorrhage. Ophthalmology 108: 2273-8, 2001
53. Shakin JL, Yannuzzi LA: Posterior segment manifestations of orbital trauma. Adv Ophthalmic Plast Reconstr Surg 6: 115-35, 1987
54. Moshetova LK, Bendelik EK, Alekseev IB, et al: [Contusions of the eye, their clinical picture and outcomes]. Vestn Oftalmol 115: 10-3, 1999
55. Stein JD, Jaeger EA, Jeffers JB: Air bags and ocular injuries. Trans Am Ophthalmol Soc 97: 59-82; discussion 82-6, 1999
56. Lam SR, Devenyi RG, Berger AR, et al: Visual outcome following penetrating globe injuries with retained intraocular foreign bodies. Can J Ophthalmol 34: 389-93, 1999
57. Shaw HE, Landers MB, Sydnor CF: The significance of intraocular hemorrhages due to subarachnoid hemorrhage. Ann Ophthalmol 9: 1403-5, 1977
58. Garfinkle AM, Danys IR, Nicolle DA, et al: Terson's syndrome: a reversible cause of blindness following subarachnoid hemorrhage. J Neurosurg 76: 766-71, 1992
59. Fahmy JA: Fundal haemorrhages in ruptured intracranial aneurysms. II. Correlation with the clinical course. Acta Ophthalmol (Copenh) 51: 299-304, 1973
60. Toosi SH, Malton M: Terson's syndrome-significance of ocular findings. Ann Ophthalmol 19: 7-12, 1987
61. Williams DF, Mieler WF, Williams GA: Posterior segment manifestations of ocular trauma. Retina 10 Suppl 1: S35-44, 1990
62. Friberg TR, Braunstein RA, Bressler NM: Sudden visual loss associated with sexual activity. Arch Ophthalmol 113: 738-42, 1995
63. Bressler NM, Bressler SB, Childs AL, et al: Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13. Ophthalmology 111: 1993-2006, 2004
64. Cunliffe IA, Rennie IG: Choroidal melanoma presenting as vitreous haemorrhage. Eye 7: 711-3, 1993
65. Spaide RF, Swengel RM, Scharre DW, et al: Shaken baby syndrome. Am Fam Physician 41: 1145-52, 1990
66. Munger CE, Peiffer RL, Bouldin TW, et al: Ocular and associated neuropathologic observations in suspected whiplash shaken infant syndrome. A retrospective study of 12 cases. Am J Forensic Med Pathol 14: 193-200, 1993
67. Riffenburgh RS, Sathyavagiswaran L: Ocular findings at autopsy of child abuse victims. Ophthalmology 98: 1519-24, 1991
68. Wilkinson WS, Han DP, Rappley MD, et al: Retinal hemorrhage predicts neurologic injury in the shaken baby syndrome. Arch Ophthalmol 107: 1472-4, 1989
69. Matthews GP, Das A: Dense vitreous hemorrhages predict poor visual and neurological prognosis in infants with shaken baby syndrome. J Pediatr Ophthalmol Strabismus 33: 260-5, 1996
70. George ND, Yates JR, Moore AT: Clinical features in affected males with X-linked retinoschisis. Arch Ophthalmol 114: 274-80, 1996
71. Regillo CD, Tasman WS, Brown GC: Surgical management of complications associated with X-linked retinoschisis. Arch Ophthalmol 111: 1080-6, 1993
72. Regillo CD, Custis PH: Surgical management of retinoschisis. Curr Opin Ophthalmol 8: 80-6, 1997
73. Rosenfeld PJ, Flynn HW, McDonald HR, et al: Outcomes of vitreoretinal surgery in patients with X-linked retinoschisis. Ophthalmic Surg Lasers 29: 190-7, 1998
74. Dahl N, Pettersson U: Use of linked DNA probes for carrier detection and diagnosis of X-linked juvenile retinoschisis. Arch Ophthalmol 106: 1414-6, 1988
75. Cassoux N, Fardeau C, Lehoang P: [Ocular manifestations of Behçet's disease]. Ann Med Interne (Paris) 150: 529-34, 1999
76. Lobo A, Barton K, Minassian D, et al: Visual loss in sarcoid-related uveitis. Clin Experiment Ophthalmol 31: 310-6, 2003
77. Gaynon MW, Boldrey EE, Strahlman ER, et al: Retinal neovascularization and ocular toxoplasmosis. Am J Ophthalmol 98: 585-9, 1984
78. Kranias G: Vitreous hemorrhage secondary to presumed ocular histoplasmosis syndrome. Ann Ophthalmol 17: 295-8, 302, 1985
79. Atmaca LS, Batioglu F, Atmaca Sonmez P: A long-term follow-up of Eales' disease. Ocul Immunol Inflamm 10: 213-21, 2002
80. McDonald HR: Diagnostics and therapeutic challenges. IRVAN syndrome. Retina 23: 392-9, 2003
81. Au A, O'Day J: Review of severe vaso-occlusive retinopathy in systemic lupus erythematosus and the antiphospholipid syndrome: associations, visual outcomes, complications and treatment. Clin Experiment Ophthalmol 32: 87-100, 2004
82. Bonfioli AA, Damico FM, Curi AL, et al: Intermediate uveitis. Semin Ophthalmol 20: 147-54, 2005
83. Kincaid MC, Green WR: Ocular and orbital involvement in leukemia. Surv Ophthalmol 27: 211-32, 1983
84. Kobayashi H, Honda Y: Intraocular hemorrhage in a patient with hemophilia. Metab Ophthalmol 8: 27-30, 1984
85. Lertsumitkul S, Whitcup SM, Chan CC: Ocular manifestations of disseminated intravascular coagulation in a patient with the acquired immunodeficiency syndrome. Arch Ophthalmol 115: 676-7, 1997
86. Wiznia RA, Price J: Vitreous hemorrhages and disseminated intravascular coagulation in the newborn. Am J Ophthalmol 82: 222-6, 1976
87. Kleiner RC, Najarian LV, Schatten S, et al: Vaso-occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy). Ophthalmology 96: 896-904, 1989
88. Scott IU, Smiddy WE, Feuer WJ, et al: The impact of echography on evaluation and management of posterior segment disorders. Am J Ophthalmol 137: 24-9, 2004
89. DiBernardo C, Blodi B, Byrne SF: Echographic evaluation of retinal tears in patients with spontaneous vitreous hemorrhage. Arch Ophthalmol 110: 511-4, 1992
90. Rabinowitz R, Yagev R, Shoham A, et al: Comparison between clinical and ultrasound findings in patients with vitreous hemorrhage. Eye 18: 253-6, 2004
91. Zacks DN, Hart L, Young LH: Ultrasonography in the traumatized eye: intraocular foreign body versus artifact. Int Ophthalmol Clin 42: 121-8, 2002
92. Sawada A, Fraser SL, Ossoinig KC: The role of ultrasound in the management of ocular foreign bodies, in White BR (ed): Ultrasound in Medicine, New York, Plenum Press, 1977, p 1003
93. Lakhanpal RR, Humayun MS, de Juan E, et al: Outcomes of 140 consecutive cases of 25-gauge transconjunctival surgery for posterior segment disease. Ophthalmology 112: 817-24, 2005
94. Shimada H, Nakashizuka H, Mori R, et al: Expanded indications for 25-gauge transconjunctival vitrectomy. Jpn J Ophthalmol 49: 397-401, 2005
95. Ibarra MS, Hermel M, Prenner JL, et al: Longer-term outcomes of transconjunctival sutureless 25-gauge vitrectomy. Am J Ophthalmol 139: 831-6, 2005
96. Thompson JT, de Bustros S, Michels RG, et al: Results and prognostic factors in vitrectomy for diabetic vitreous hemorrhage. Arch Ophthalmol 105: 191-5, 1987
97. Benson WE, Brown GC, Tasman W, et al: Complications of vitrectomy for non-clearing vitreous hemorrhage in diabetic patients. Ophthalmic Surg 19: 862-4, 1988
98. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial: Diabetic Retinopathy Vitrectomy Study Report 5. Arch Ophthalmol 108: 958-64, 1990
99. Li X, Jiang Y, Ye C, et al: Timing of vitrectomy for proliferative diabetic retinopathy in cases with type II diabetes mellitus. Zhonghua Yan Ke Za Shi 35: 116-8, 1999
100. Cooper B, Shah GK, Grand MG, et al: Visual outcomes and complications after multiple vitrectomies for diabetic vitreous hemorrhage. Retina 24: 19-22, 2004
101. Smiddy WE, Feuer W, Irvine WD, et al: Vitrectomy for complications of proliferative diabetic retinopathy. Functional outcomes. Ophthalmology 102: 1688-95, 1995
102. Thompson JT, Auer CL, de Bustros S, et al: Prognostic indicators of success and failure in vitrectomy for diabetic retinopadiy. Ophthalmology 93: 290-5, 1986
103. Mason JO, Colagross CT, Haleman T, et al: Visual outcome and risk factors for light perception and no light perception vision after vitrectomy for diabetic retinopathy. Am J Ophthalmol 140: 231-5, 2005
104. Isernhagen RD, Smiddy WE, Michels RG, et al: Vitrectomy for nondiabetic vitreous hemorrhage. Not associated with vascular disease. Retina 8: 81-7, 1988
105. Smiddy WE, Isernhagen RD, Michels RG, et al: Vitrectomy for nondiabetic vitreous hemorrhage. Retinal and choroidal vascular disorders. Retina 8: 88-95, 1988
106. Li C, Gao R: [Vitrectomy for nondiabetic vitreous hemorrhage]. Yan Ke Xue Bao 7: 95-7, 1991
107. Oyakawa RT, Michels RG, Blase WP: Vitrectomy for nondiabetic vitreous hemorrhage. Am J Ophthalmol 96: 517-25, 1983
108. Yeshaya A, Treister G: Pars plana vitrectomy for vitreous hemorrhage and retinal vein occlusion. Ann Ophthalmol 15: 615-7, 1983
109. Amirikia A, Scott IU, Murray TG, et al: Outcomes of vitreoretinal surgery for complications of branch retinal vein occlusion. Ophthalmology 108: 372-6, 2001
110. Schulman J, Peyman GA, Jednock N, et al: Indications for vitrectomy in congenital retinoschisis. Br J Ophthalmol 69: 482-6, 1985
111. Guerra A, Pastor JC: Retinal cryoapplication and fibrinolysis in experimental vitreous hemorrhage. Curr Eye Res 10: 697-701, 1991
112. Williams DF, Burke JM, Williams GA: Clearance of experimental vitreous hemorrhage after panretinal cryotherapy is related to macrophage influx. Arch Ophthalmol 108: 595-7, 1990
113. Lenkiewicz E, Stankiewicz A, Ejchartowa I, et al: [Cryotherapy of vitreous hemorrhage in diabetic retinopathy]. Klin Oczna 91: 195-6, 1989
114. Matthes R, Anders M, Matthäus W: [Cryotherapy in the treatment of vitreous hemorrhage of various origin]. Cesk Oftalmol 47: 311-6, 1991
115. Mosier MA, Del Piero E, Gheewala SM: Anterior retinal cryotherapy in diabetic vitreous hemorrhage. Am J Ophthalmol 100: 440-4, 1985
116. Mosier MA, Del Piero E: Retinal cryopexy in the management of proliferative diabetic retinopathy. Ann Ophthalmol 17: 178-81, 1985
117. Kuppermann BD, Thomas EL, de Smet MD, et al: Pooled efficacy results from two multinational randomized controlled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage. Am J Ophthalmol 140: 573-84, 2005
118. Kuppermann BD, Thomas EL, de Smet MD, et al: Safety results of two phase III trials of an intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage. Am J Ophthalmol 140: 585-97, 2005
119. Wang F, Wang Z, Sun X, et al: Safety and efficacy of dispase and plasmin in pharmacologic vitreolysis. Invest Ophthalmol Vis Sci 45: 3286-90, 2004
120. Tanaka M, Qui H: Pharmacological vitrectomy. Semin Ophthalmol 15: 51-61, 2000